Xenco Medical
| Company type | Private |
|---|---|
| Industry | Medical technology |
| Founded | 2011 |
| Founder | Jason Haider |
| Headquarters | San Diego, California , United States |
Area served | United States |
| Products | Composite polymer medical devices, disposable spinal surgery systems, CancelleX titanium foam implants, TrabeculeX Continuum |
Xenco Medical is a U.S.-based medical technology firm located in San Diego, California, specializing in the design, development, and distribution of composite polymer medical devices.
History
Established in 2011 by entrepreneur Jason Haider, Xenco Medical set out to revolutionize the conventional metal-based surgical systems market by launching the first disposable spinal surgery systems made from composite polymers. The company targeted significant issues associated with steel implant systems—such as elevated costs, variable performance, and infection hazards—and dedicated three years to research and development to create sterile, single-use reinforced plastic surgical implants.
On July 17, 2015, Xenco Medical revealed that the UCLA Spine Center had successfully conducted spine surgery utilizing its disposable plastic surgical rasps and implant inserters. This Anterior Cervical Discectomy and Fusion procedure represented the inaugural application of Xenco’s novel plastic system at a prominent U.S. hospital. The single-use instruments were discarded post-operation, thereby eliminating infection risks linked to instrument reuse.
This milestone highlighted Xenco Medical’s distinct advantage in offering cost-efficient, sterile surgical solutions that enhance patient outcomes while boosting operational efficiency within healthcare environments.
SETx Technology
On September 30, 2015, the UCSF Orthopedic Trauma Institute reported findings from a comparative strength analysis demonstrating that Xenco Medical's disposable plastic spinal instrument surpassed its metal equivalent. The UCSF research indicated that the plastic lumbar instrument preserved its structural integrity without visible fractures at 40mm cantilever deflection, whereas the aluminum device exhibited significant deformation. By removing the need for autoclave sterilization, reducing delivery delays, and minimizing infection-related extended care, Xenco Medical’s patient-specific implant systems lower overall costs. Their composite polymer instruments maintain consistent calibration, unlike traditional surgical tools that deteriorate with repeated use.
Xenco Medical’s growth underscores the robustness of its products, which stems from a proprietary interfacial bond within its reinforced composite polymer technology. The SETx Technology combines polyamide crystallinity with durable compounds embedded in a resilient fibrous matrix. This materials science innovation allows their instruments to endure substantial force loads, delivering a competitive edge in spinal surgery tools.
The ASC CerviKit
In July 2017, Xenco Medical broadened its reach nationwide by introducing a compact ASC delivery platform for its disposable Anterior Cervical Discectomy and Fusion (ACDF) system. Tailored for ambulatory surgery centers, the ASC CerviKit encompasses all of Xenco Medical's single-use cervical implant lines. This lightweight platform simplifies the ACDF procedure while addressing space limitations common in surgery centers. It includes pre-loaded cervical interbodies, pre-loaded cervical plates, and complementary single-use instruments. The ASC CerviKit features Xenco Medical's Merge Cervical Plate system—a single-use solution incorporating the company's Snap-Align technology—reflecting a strategic emphasis on efficient care delivery.
Surgical Vending Machine
In June 2019, Xenco Medical pioneered the first-ever surgical vending machine tailored for spine surgery tools and implants. Outfitted with wifi connectivity, a touchscreen interface, and a sophisticated elevator retrieval mechanism, each unit can store up to 260 sterile-packaged Xenco Medical items, customizable to meet specific hospital requirements. These machines also offer virtual tutorials featuring a digital assistant named Ezra to facilitate product usage. Inventory updates are transmitted in real time to Xenco Medical’s headquarters, enabling streamlined stock management and exemplifying the company’s innovative approach to surgical supply distribution.
CancelleX Titanium Foam Implants
Xenco Medical launched its CancelleX titanium foam spinal implants nationwide in June 2020. Designed with a bio-inspired structure that encourages bone attachment and blood vessel growth, these implants mimic a sponge-like form capable of capillary action. Manufactured through injection molding from titanium foam and pre-attached to disposable composite polymer instruments, they exhibit interconnected porosity throughout the implant. This breakthrough technology promotes enhanced bone integration and marks a notable progression in spinal implant solutions, reinforcing Xenco Medical’s leadership in spinal surgery products and services.
TrabeculeX Continuum
At the 2024 Consumer Electronics Show (CES) in Las Vegas, Xenco Medical introduced the TrabeculeX Continuum,, representing a pivotal development in the company’s strategic direction. This innovation received Fast Company Magazine’s 2024 Innovation by Design Award. The TrabeculeX Continuum combines orthobiologics with digital health by merging biomaterial implantation with postoperative care via a regenerative biomaterial engineered for 3D bone growth alongside a remote therapeutic monitoring application. This advancement connects surgical intervention with complete mobility restoration, addressing the fragmented aspects of current surgical care and enhancing Xenco Medical’s stature within regenerative medicine.
Awards and recognition
The expansion of Xenco Medical is highlighted by numerous honors: the 2024 Innovation by Design Award from Fast Company for the TrabeculeX Continuum, inclusion on Inc. Magazine’s June 2024 list of America’s best workplaces, placement on Fast Company’s 2023 roster of the World’s Most Innovative Companies, and receipt of the World Economic Forum’s 2022 New Champions Award for Excellence in Sustainable Growth. Founder and CEO Jason Haider has earned ongoing recognition for his strategic leadership, being named among San Diego Business Journal’s Top 50 Life Science Leaders from 2022 through 2024 and featured among San Diego’s 500 Most Influential People in 2021, underscoring his significant influence as an entrepreneur and leader in the life sciences sector.